|
|
Volumn 42, Issue 1, 2012, Pages 34-35
|
|
RCPE UK consensus conference on 'Approaching the comprehensive management of atrial fibrillation: Evolution or revolution?'
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
CLOPIDOGREL;
THROMBIN INHIBITOR;
WARFARIN;
ABLATION THERAPY;
ANTICOAGULANT THERAPY;
BLEEDING;
BRAIN ISCHEMIA;
CARDIOEMBOLIC STROKE;
CONSENSUS;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
DRUG SAFETY;
DRUG UPTAKE;
ELECTROCARDIOGRAM;
EXPECTATION;
HEART ATRIUM FIBRILLATION;
HEART RATE;
HEART RHYTHM;
HUMAN;
MEDICAL DECISION MAKING;
NOTE;
PALLIATIVE THERAPY;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PATIENT DECISION MAKING;
PHYSICIAN ATTITUDE;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SCREENING TEST;
STROKE;
THROMBOSIS PREVENTION;
UNITED KINGDOM;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
ATRIAL FIBRILLATION;
DELIVERY OF HEALTH CARE;
DISEASE MANAGEMENT;
GREAT BRITAIN;
HUMANS;
SOCIETIES, MEDICAL;
ANTICOAGULANTS;
CONSENSUS;
GUIDELINES AS TOPIC;
|
|
EID: 84861168632
PISSN: 14782715
EISSN: None
Source Type: Journal
DOI: 10.4997/JRCPE.2012.S01 Document Type: Note |
|
Times cited : (30)
|
|
References (0)
|
